Ralf DieckhoffVP North America at DPL-US (dba. Dr. Paul Lohmann, Inc.)
After earning his degree at the Bioprocess Department of the University of Applied Sciences, Hannover, Germany, in 1995, Ralf Dieckhoff first pursued a career aat a plant engineering company, serving the food, pharmaceutical and bio-processing industry.
In 1997 he assumed the position of Technical Director at Nupron GmbH, a biotech start-up near Goettingen, Germany. At Nupron Ralf developed numerous proprietary processes for the company's newly invented technologies for creating defined poly-peptides by enzymatic hydrolyzation and multi-stage fractionation.
In 2002, after the acquisition of Nupron by DMV-International, Ralf accepted the position as project leader in a multi-national business development project at DMV's business unit HQ in Delhi, NY. In this role he headed the realization of the industrial scale manufacturing and commercialization of activated Lactoferrin (aLF), a chromatographically extracted bioactive protein.
In 2007 he accepted the position of VP North America for Dr. Paul Lohmann GmbH KG in Emmerthal Germany, the world's leading manufacturer of high value minerals and chemical salts for the nutritional, personal care and pharmaceutical industries. In 2009 he transitioned to the company's new US entity on Long Island, NY, now operating under the name DPL-US. Building on his background and meanwhile 30 years of experience in biotechnologies, Ralf has been spearheading the company’s initiatives for bio-processing applications.